The stock of Cronos Group Inchare (NASDAQ:CRON) registered a decrease of 4.56% in short interest. CRON’s total short interest was 28.68M shares in February as published by FINRA. Its down 4.56% from 30.05 million shares, reported previously. With 9.60 million shares average volume, it will take short sellers 3 days to cover their CRON’s short positions. The short interest to Cronos Group Inchare’s float is 19.11%.
The stock increased 2.25% or $0.44 during the last trading session, reaching $19.99. About 17.65M shares traded or 19.03% up from the average. Cronos Group Inc. (NASDAQ:CRON) has risen 277.71% since February 11, 2018 and is uptrending. It has outperformed by 277.71% the S&P500.
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The company has market cap of $3.59 billion. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations . It currently has negative earnings. The firm typically invests in companies based in Canada.
Posts
